BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results

BioCryst Pharma (BCRX) Posts Q4 Loss of 9c/Share

February 26, 2014 6:53 AM EST

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $8.81 million.

Financial Outlook for 2014

Based upon current trends, assumptions, and development... More